Macquarie Group LTD Abb Vie Inc. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 500,154 shares of ABBV stock, worth $97.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

500,154

Previous 443,925 12.67%

Holding current value

$97.4 Million

Previous $80.8 Million 6.12%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $8.7 Million - $10.2 Million	56,229 Added 12.67%	500,154 $85.8 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $11.5 Million - $13.1 Million	-71,668 Reduced 13.9%	443,925 $80.8 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $34.2 Million - $38.5 Million	-248,602 Reduced 32.53%	515,593 $79.9 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $43.2 Million - $50 Million	323,367 Added 73.35%	764,195 $114 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $8.99 Million - $11.2 Million	-67,809 Reduced 13.33%	440,828 $59.4 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $7.53 Million - $8.67 Million	52,064 Added 11.4%	508,637 $81.1 Million
Q4 2022 Feb 21, 2023	BUY	$138.31 - $165.87 $2.61 Million - $3.13 Million	18,881 Added 4.31%	456,573 $73.8 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $4.17 Million - $4.78 Million	-31,065 Reduced 6.63%	437,692 $58.7 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $14.4 Million - $18.4 Million	-104,976 Reduced 18.3%	468,757 $71.8 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $21.4 Million - $26.5 Million	-161,885 Reduced 22.01%	573,733 $93 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $2.5 Million - $3.17 Million	-23,294 Reduced 3.07%	735,618 $99.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $14.5 Million - $16.4 Million	-135,931 Reduced 15.19%	758,912 $81.9 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $7.87 Million - $8.77 Million	-74,827 Reduced 7.72%	894,843 $101 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $30.4 Million - $33.5 Million	297,561 Added 44.27%	969,670 $105 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $10 Million - $13.6 Million	124,760 Added 22.79%	672,109 $72 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $9.65 Million - $11.3 Million	112,365 Added 25.83%	547,349 $47.9 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $10.3 Million - $13.8 Million	140,866 Added 47.89%	434,984 $42.7 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $8.19 Million - $12.4 Million	126,981 Added 75.97%	294,118 $22.4 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $201,819 - $252,519	-2,798 Reduced 1.65%	167,137 $14.8 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $4.62 Million - $5.55 Million	-73,287 Reduced 30.13%	169,935 $12.9 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $767,376 - $980,886	-11,680 Reduced 4.58%	243,222 $17.7 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $291,589 - $343,186	-3,780 Reduced 1.46%	254,902 $20.5 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $12.1 Million - $14.9 Million	-154,986 Reduced 37.47%	258,682 $23.8 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $2.54 Million - $2.83 Million	-28,620 Reduced 6.47%	413,668 $39.1 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.16 Million - $1.37 Million	12,938 Added 3.01%	442,288 $41 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $4.72 Million - $6.32 Million	-51,316 Reduced 10.68%	429,350 $40.6 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $12.9 Million - $14.1 Million	143,538 Added 42.58%	480,666 $46.6 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $23.5 Million - $30.1 Million	337,128	337,128 $30 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Abb Vie Inc. Transaction History